HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of 5-azacytidine and its analogues on blast cell renewal in acute myeloblastic leukemia.

Abstract
Blast cells from patients with acute myeloblastic leukemia were exposed to 5-azacytidine (5-aza) and its analogues 5-aza 2'-deoxycytidine (5-aza-dr) and 6-azacytidine (6-aza). Simple negative exponential survival curves were obtained for the three drugs, but the sensitivity varied; 5-aza-dr was most toxic, 6-aza was least toxic, and 5-aza was intermediate. Colonies surviving drug exposure were replated; 5-aza and 5-aza-dr were found to increase secondary plating efficiency, whereas 6-aza was inactive. The findings provide indirect evidence for a role for DNA methylation in the regulation of blast cell self-renewal.
AuthorsT Motoji, T Hoang, D Tritchler, E A McCulloch
JournalBlood (Blood) Vol. 65 Issue 4 Pg. 894-901 (Apr 1985) ISSN: 0006-4971 [Print] United States
PMID2579689 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Culture Media
  • Decitabine
  • Azacitidine
  • 6-azacytidine
Topics
  • Azacitidine (analogs & derivatives, pharmacology)
  • Cell Division (drug effects)
  • Culture Media
  • Decitabine
  • Dose-Response Relationship, Drug
  • Humans
  • Leukemia, Myeloid, Acute (blood, pathology)
  • Neoplastic Stem Cells (drug effects)
  • Phenotype
  • Stem Cells (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: